Rice, J. C. & Allis, C. D. Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr. Opin. Cell Biol.13, 263–273 (2001). CASPubMed Google Scholar
Shilatifard, A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu. Rev. Biochem.75, 243–269 (2006). CASPubMed Google Scholar
Sparmann, A. & van Lohuizen, M. Polycomb silencers control cell fate, development and cancer. Nature Rev. Cancer6, 846–856 (2006). CAS Google Scholar
Ayton, P. M. & Cleary, M. L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene20, 5695–5707 (2001). CASPubMed Google Scholar
Biondi, A., Cimino, G., Pieters, R. & Pui, C. H. Biological and therapeutic aspects of infant leukemia. Blood96, 24–33 (2000). CASPubMed Google Scholar
Huret, J. L., Dessen, P. & Bernheim, A. An atlas of chromosomes in hematological malignancies. Example: 11q23 and MLL partners. Leukemia15, 987–989 (2001). CASPubMed Google Scholar
Meyer, C. et al. The MLL recombinome of acute leukemias. Leukemia20, 777–784 (2006). CASPubMed Google Scholar
Chen, C. S. et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood81, 2386–2393 (1993). CASPubMed Google Scholar
Felix, C. A. et al. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood85, 3250–3256 (1995). CASPubMed Google Scholar
Mrozek, K. et al. Adult patients with de novo acute myeloid leukemia and t(9;11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Blood90, 4532–4538 (1997). CASPubMed Google Scholar
Rubnitz, J. E. et al. Favorable impact of the t(9;11) in childhood acute myeloid leukemia. J. Clin. Oncol.20, 2302–2309 (2002). CASPubMed Google Scholar
Gu, Y. et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell71, 701–708 (1992). CASPubMed Google Scholar
Tkachuk, D. C., Kohler, S. & Cleary, M. L. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell71, 691–700 (1992). CASPubMed Google Scholar
Butler, L. H., Slany, R., Cui, X., Cleary, M. L. & Mason, D. Y. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures. Blood89, 3361–3370 (1997). CASPubMed Google Scholar
Kawagoe, H., Humphries, R. K., Blair, A., Sutherland, H. J. & Hogge, D. E. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia13, 687–698 (1999). CASPubMed Google Scholar
Phillips, R. L. et al. The genetic program of hematopoietic stem cells. Science288, 1635–1640 (2000). CASPubMed Google Scholar
Daser, A. & Rabbitts, T. H. Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev.18, 965–674 (2004). CASPubMed Google Scholar
Popovic, R. & Zeleznik-Le, N. J. MLL: how complex does it get? J. Cell Biochem.95, 234–242 (2005). CASPubMed Google Scholar
Ernst, P., Wang, J., Huang, M., Goodman, R. H. & Korsmeyer, S. J. MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein. Mol. Cell Biol.21, 2249–2258 (2001). CASPubMedPubMed Central Google Scholar
Briggs, S. D. et al. Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae. Genes Dev.15, 3286–3295 (2001). CASPubMedPubMed Central Google Scholar
Milne, T. A. et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell10, 1107–1117 (2002). This paper and reference28were the first to demonstrate H3K4 methyltransferase activity of the SET domain in mammalian MLL. CASPubMed Google Scholar
Dou, Y. et al. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nature Struct. Mol. Biol.13, 713–719 (2006). CAS Google Scholar
Steward, M. M. et al. Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nature Struct. Mol. Biol.13, 852–854 (2006). CAS Google Scholar
Couture, J. F., Collazo, E. & Trievel, R. C. Molecular recognition of histone H3 by the WD40 protein WDR5. Nature Struct. Mol. Biol.13, 698–703 (2006). CAS Google Scholar
Crawford, B. D. & Hess, J. L. MLL core components give the green light to histone methylation. ACS Chem. Biol.1, 495–498 (2006). CASPubMed Google Scholar
Sims, R. J. III & Reinberg, D. Histone H3 Lys 4 methylation: caught in a bind? Genes Dev.20, 2779–2786 (2006). CASPubMed Google Scholar
Nakamura, T. et al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell10, 1119–1128 (2002). CASPubMed Google Scholar
Yokoyama, A. et al. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol. Cell Biol.24, 5639–5649 (2004). CASPubMedPubMed Central Google Scholar
Dou, Y. et al. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell121, 873–885 (2005). CASPubMed Google Scholar
Zeleznik-Le, N. J., Harden, A. M. & Rowley, J. D. 11q23 translocations split the “AT-hook” cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. Proc. Natl Acad. Sci. USA91, 10610–10614 (1994). CASPubMedPubMed Central Google Scholar
Birke, M. et al. The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation. Nucleic Acids Res.30, 958–965 (2002). CASPubMedPubMed Central Google Scholar
Yokoyama, A. et al. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell123, 207–218 (2005). CASPubMed Google Scholar
Xia, Z. B., Anderson, M., Diaz, M. O. & Zeleznik-Le, N. J. MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc. Natl Acad. Sci. USA100, 8342–8347 (2003). CASPubMedPubMed Central Google Scholar
Abramovich, C. & Humphries, R. K. Hox regulation of normal and leukemic hematopoietic stem cells. Curr. Opin. Hematol.12, 210–216 (2005). CASPubMed Google Scholar
Yu, B. D., Hess, J. L., Horning, S. E., Brown, G. A. & Korsmeyer, S. J. Altered Hox expression and segmental identity in Mll-mutant mice. Nature378, 505–508 (1995). CASPubMed Google Scholar
Yagi, H. et al. Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice. Blood92, 108–117 (1998). CASPubMed Google Scholar
Terranova, R., Agherbi, H., Boned, A., Meresse, S. & Djabali, M. Histone and DNA methylation defects at Hox genes in mice expressing a SET domain-truncated form of Mll. Proc. Natl Acad. Sci. USA103, 6629–6634 (2006). CASPubMedPubMed Central Google Scholar
Hanson, R. D. et al. Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development. Proc. Natl Acad. Sci. USA96, 14372–14377 (1999). CASPubMedPubMed Central Google Scholar
Guenther, M. G. et al. Global and Hox-specific roles for the MLL1 methyltransferase. Proc. Natl Acad. Sci. USA102, 8603–8608 (2005). CASPubMedPubMed Central Google Scholar
Hess, J. L., Yu, B. D., Li, B., Hanson, R. & Korsmeyer, S. J. Defects in yolk sac hematopoiesis in Mll-null embryos. Blood90, 1799–1806 (1997). CASPubMed Google Scholar
Ernst, P. et al. Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev. Cell6, 437–443 (2004). CASPubMed Google Scholar
Pardal, R., Molofsky, A. V., He, S. & Morrison, S. J. Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Cold Spring Harb. Symp. Quant. Biol.70, 177–185 (2005). CASPubMed Google Scholar
Lessard, J. & Sauvageau, G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature423, 255–260 (2003). CASPubMed Google Scholar
Park, I. K. et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature423, 302–305 (2003). CASPubMed Google Scholar
Milne, T. A. et al. MLL associates specifically with a subset of transcriptionally active target genes. Proc. Natl Acad. Sci. USA102, 14765–14770 (2005). CASPubMedPubMed Central Google Scholar
Richardson, C. & Jasin, M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature405, 697–700 (2000). CASPubMed Google Scholar
Strissel, P. L., Strick, R., Rowley, J. D. & Zeleznik-Le, N. J. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood92, 3793–3803 (1998). CASPubMed Google Scholar
So, C. W., Lin, M., Ayton, P. M., Chen, E. H. & Cleary, M. L. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell4, 99–110 (2003). CASPubMed Google Scholar
So, C. W. & Cleary, M. L. Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood101, 633–639 (2003). CASPubMed Google Scholar
Hall, P. A. & Russell, S. E. The pathobiology of the septin gene family. J. Pathol.204, 489–505 (2004). CASPubMed Google Scholar
Ida, K. et al. Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood90, 4699–4704 (1997). CASPubMed Google Scholar
Taki, T., Sako, M., Tsuchida, M. & Hayashi, Y. The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood89, 3945–3950 (1997). CASPubMed Google Scholar
Rowley, J. D. et al. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood90, 535–541 (1997). CASPubMed Google Scholar
Caligiuri, M. A. et al. Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res.56, 1418–1425 (1996). CASPubMed Google Scholar
Schichman, S. A. et al. ALL-1 partial duplication in acute leukemia. Proc. Natl Acad. Sci. USA91, 6236–6239 (1994). CASPubMedPubMed Central Google Scholar
Lochner, K. et al. A specific deletion in the breakpoint cluster region of the ALL-1 gene is associated with acute lymphoblastic T-cell leukemias. Cancer Res.56, 2171–2177 (1996). CASPubMed Google Scholar
Slany, R. K., Lavau, C. & Cleary, M. L. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX. Mol. Cell Biol.18, 122–129 (1998). CASPubMedPubMed Central Google Scholar
Milne, T. A., Martin, M. E., Brock, H. W., Slany, R. K. & Hess, J. L. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. Cancer Res.65, 11367–11374 (2005). CASPubMed Google Scholar
Corral, J. et al. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell85, 853–861 (1996). Demonstrates thatMll–AF9induces leukaemia in mice and describes a method for the generation of 'knock-in' mouse models of translocation-associated human leukaemias. CASPubMed Google Scholar
Collins, E. C., Pannell, R., Simpson, E. M., Forster, A. & Rabbitts, T. H. Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development. EMBO Rep.1, 127–132 (2000). CASPubMedPubMed Central Google Scholar
Forster, A. et al. Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer. Cancer Cell3, 449–458 (2003). CASPubMed Google Scholar
Wang, J. et al. Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. EMBO J.24, 368–381 (2005). PubMedPubMed Central Google Scholar
Chen, W. et al. A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy. Blood108, 669–677 (2006). CASPubMedPubMed Central Google Scholar
Metzler, M. et al. A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology. Oncogene25, 3093–3103 (2006). CASPubMed Google Scholar
Lavau, C., Szilvassy, S. J., Slany, R. & Cleary, M. L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J.16, 4226–4237 (1997). CASPubMedPubMed Central Google Scholar
So, C. W. et al. MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell3, 161–171 (2003). CASPubMed Google Scholar
Zeisig, B. B., Garcia-Cuellar, M. P., Winkler, T. H. & Slany, R. K. The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell. Oncogene22, 1629–1637 (2003). CASPubMed Google Scholar
Barabe, F., Kennedy, J. A., Hope, K. J. & Dick, J. E. Modeling the initiation and progression of human acute leukemia in mice. Science316, 600–604 (2007). CASPubMed Google Scholar
Yu, M. et al. MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype. Leukemia10, 774–780 (1996). CASPubMed Google Scholar
Caligiuri, M. A. et al. The partial tandem duplication of ALL1 in acute myeloid leukemia with normal cytogenetics or trisomy 11 is restricted to one chromosome. Proc. Natl Acad. Sci. USA94, 3899–3902 (1997). CASPubMedPubMed Central Google Scholar
Dorrance, A. M. et al. Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. J. Clin. Invest.116, 2707–2716 (2006). CASPubMedPubMed Central Google Scholar
Dobson, C. L., Warren, A. J., Pannell, R., Forster, A. & Rabbitts, T. H. Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene. EMBO J.19, 843–851 (2000). CASPubMedPubMed Central Google Scholar
Bernard, O. A., Mauchauffe, M., Mecucci, C., Van den Berghe, H. & Berger, R. A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL. Oncogene9, 1039–1045 (1994). CASPubMed Google Scholar
Megonigal, M. D. et al. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Proc. Natl Acad. Sci. USA97, 2814–2819 (2000). CASPubMedPubMed Central Google Scholar
Slany, R. K. When epigenetics kills: MLL fusion proteins in leukemia. Hematol. Oncol.23, 1–9 (2005). CASPubMed Google Scholar
Shilatifard, A., Lane, W. S., Jackson, K. W., Conaway, R. C. & Conaway, J. W. An RNA polymerase II elongation factor encoded by the human ELL gene. Science271, 1873–1876 (1996). CASPubMed Google Scholar
Simone, F. et al. EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein. Blood98, 201–209 (2001). CASPubMed Google Scholar
Garcia-Cuellar, M. P. et al. ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+. Oncogene19, 1744–1751 (2000). CASPubMed Google Scholar
Prasad, R. et al. Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proc. Natl Acad. Sci. USA92, 12160–12164 (1995). CASPubMedPubMed Central Google Scholar
So, C. W. & Cleary, M. L. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function. Mol. Cell Biol.22, 6542–6552 (2002). CASPubMedPubMed Central Google Scholar
Erfurth, F., Hemenway, C. S., de Erkenez, A. C. & Domer, P. H. MLL fusion partners AF4 and AF9 interact at subnuclear foci. Leukemia18, 92–102 (2004). CASPubMed Google Scholar
Okada, Y. et al. hDOT1L links histone methylation to leukemogenesis. Cell121, 167–178 (2005). Identifies a unique function of an MLL fusion (MLL–AF10). The recruitment of the H3K79 methyltransferase DOT1L by AF10 is necessary for transformation. CASPubMed Google Scholar
Guenther, M. G., Levine, S. S., Boyer, L. A., Jaenisch, R. & Young, R. A. A chromatin landmark and transcription initiation at most promoters in human cells. Cell130, 77–88 (2007). CASPubMedPubMed Central Google Scholar
Lachner, M., O'Sullivan, R. J. & Jenuwein, T. An epigenetic road map for histone lysine methylation. J. Cell Sci.116, 2117–2124 (2003). CASPubMed Google Scholar
Zhang, W., Xia, X., Reisenauer, M. R., Hemenway, C. S. & Kone, B. C. Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCα in an aldosterone-sensitive manner. J. Biol. Chem.281, 18059–18068 (2006). CASPubMed Google Scholar
Bitoun, E., Oliver, P. L. & Davies, K. E. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum. Mol. Genet.16, 92–106 (2007). CASPubMed Google Scholar
Zeisig, D. T. et al. The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin. Oncogene24, 5525–5532 (2005). CASPubMed Google Scholar
So, C. W. et al. The interaction between EEN and Abi-1, two MLL fusion partners, and synaptojanin and dynamin: implications for leukaemogenesis. Leukemia14, 594–601 (2000). CASPubMed Google Scholar
Cozzio, A. et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev.17, 3029–3035 (2003). Demonstrates direct transformation of committed myeloid progenitors by an MLL fusion. This finding suggests that cells incapable of self renewal can be transformed by certain oncogenes. CASPubMedPubMed Central Google Scholar
Na Nakorn, T., Traver, D., Weissman, I. L. & Akashi, K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU.-S. J. Clin. Invest.109, 1579–1585 (2002). PubMedPubMed Central Google Scholar
Huntly, B. J. et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell6, 587–596 (2004). CASPubMed Google Scholar
Miller, C. T., Maves, L. & Kimmel, C. B. moz regulates Hox expression and pharyngeal segmental identity in zebrafish. Development131, 2443–2461 (2004). CASPubMed Google Scholar
Deguchi, K. et al. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell3, 259–271 (2003). CASPubMed Google Scholar
Dick, J. E. & Lapidot, T. Biology of normal and acute myeloid leukemia stem cells. Int. J. Hematol.82, 389–396 (2005). CASPubMed Google Scholar
Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature414, 105–111 (2001). CASPubMed Google Scholar
Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med.3, 730–737 (1997). CASPubMed Google Scholar
Passegue, E., Wagers, A. J., Giuriato, S., Anderson, W. C. & Weissman, I. L. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J. Exp. Med.202, 1599–1611 (2005). CASPubMedPubMed Central Google Scholar
Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature442, 818–822 (2006). CASPubMed Google Scholar
Somervaille, T. C. & Cleary, M. L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell10, 257–268 (2006). CASPubMed Google Scholar
Kroon, E. et al. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J.17, 3714–3725 (1998). CASPubMedPubMed Central Google Scholar
Griffin, J. D. & Lowenberg, B. Clonogenic cells in acute myeloblastic leukemia. Blood68, 1185–1195 (1986). CASPubMed Google Scholar
Opferman, J. T. et al. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science307, 1101–1104 (2005). CASPubMed Google Scholar
Terskikh, A. V., Miyamoto, T., Chang, C., Diatchenko, L. & Weissman, I. L. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood102, 94–101 (2003). CASPubMed Google Scholar
Scharenberg, C. W., Harkey, M. A. & Torok-Storb, B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood99, 507–512 (2002). CASPubMed Google Scholar
Yilmaz, O. H. et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature441, 475–482 (2006). CASPubMed Google Scholar
Krause, D. S., Lazarides, K., von Andrian, U. H. & Van Etten, R. A. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nature Med.12, 1175–1180 (2006). CASPubMed Google Scholar
Deshpande, A. J. et al. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell10, 363–374 (2006). CASPubMed Google Scholar
Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F. & Dick, J. E. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nature Med.12, 1167–1174 (2006). PubMed Google Scholar
Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126, 663–676 (2006). A landmark paper demonstrating the ability to induce cellular reprogramming from fibroblasts to ES cells with a limited number of genes. CASPubMed Google Scholar
Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature448, 313–317 (2007). CASPubMed Google Scholar
Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature448, 318–324 (2007). CASPubMed Google Scholar
Feinberg, A. P. Phenotypic plasticity and the epigenetics of human disease. Nature447, 433–440 (2007). CASPubMed Google Scholar
Esteller, M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nature Rev. Genet.8, 286–298 (2007). CASPubMed Google Scholar
Francis, N. J., Kingston, R. E. & Woodcock, C. L. Chromatin compaction by a polycomb group protein complex. Science306, 1574–1577 (2004). CASPubMed Google Scholar
Papp, B. & Muller, J. Histone trimethylation and the maintenance of transcriptional ON and OFF states by trxG and PcG proteins. Genes Dev.20, 2041–2054 (2006). CASPubMedPubMed Central Google Scholar
Schuettengruber, B., Chourrout, D., Vervoort, M., Leblanc, B. & Cavalli, G. Genome regulation by polycomb and trithorax proteins. Cell128, 735–745 (2007). CASPubMed Google Scholar
De Braekeleer, M., Morel, F., Le Bris, M. J., Herry, A. & Douet-Guilbert, N. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia. Anticancer Res.25, 1931–1944 (2005). CASPubMed Google Scholar
Fair, K. et al. Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells. Mol. Cell Biol.21, 3589–3597 (2001). CASPubMedPubMed Central Google Scholar
Cheung, N., Chan, L. C., Thompson, A., Cleary, M. L. & Eric So, C. W. Protein arginine-methyltransferase-dependent oncogenesis. Nature Cell Biol. 23 September 2007 [Epub ahead of print]. Google Scholar